Giant Cell Arteritis (GCA) Overview
Learn About Giant Cell Arteritis (GCA)
- Giant cell arteritis
- Arteritis cranialis
- Arteritis temporalis
- Cranial arteritis
- GCA
- Horton's arteritis
- Horton's giant cell arteritis
- Horton's temporal arteritis
- Horton’s disease
- Horton’s syndrome
- Temporal arteritis
Miguel Gay-Gonzalez practices in Santander And Univ. Of The Witwatersrand, South Africa. Mr. Gay-Gonzalez is rated as an Elite expert by MediFind in the treatment of Giant Cell Arteritis (GCA). His top areas of expertise are Vasculitis, Giant Cell Arteritis (GCA), Temporal Arteritis, Lung Transplant, and Kidney Transplant.
Eric Matteson is a Rheumatologist in Rochester, Minnesota. Dr. Matteson is rated as an Elite provider by MediFind in the treatment of Giant Cell Arteritis (GCA). His top areas of expertise are Polymyalgia Rheumatica, Rhizomelic Pseudopolyarthritis, Temporal Arteritis, Giant Cell Arteritis (GCA), and Tissue Biopsy.
Mayo Clinic
Kenneth Warrington is a Rheumatologist in Rochester, Minnesota. Dr. Warrington is rated as an Elite provider by MediFind in the treatment of Giant Cell Arteritis (GCA). His top areas of expertise are Temporal Arteritis, Giant Cell Arteritis (GCA), Vasculitis, Takayasu Arteritis, and Tissue Biopsy. Dr. Warrington is currently accepting new patients.
Background: \- Vasculitis is a group of diseases that inflame and damage blood vessels and tissue. It can cause many medical problems. Few tests can diagnose the disease, and none can reliably predict a relapse. Researchers want to study people s genes and follow people over time to see how the disease affects them.
Summary: Giant cell arteritis (GCA) is a large-vessel vasculitis that typically occurs in people over the age of 50. Corticosteroids (GC) are the cornerstone of treatment for GCA. French guidelines recommend starting at 0.7 or 1 mg/kg/day at diagnosis, depending on the occurence of ischemic complication(s). Then, it is recommended to gradually decrease their dose to achieve withdrawal in 12 to 24 months. D...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

